Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators

Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators

US Patent 7329654 · Granted Feb 12, 2008

Estimated economic value: $111,561,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method and composition for promoting cell growth and tissue repair2025
Acylsulfonamide KAT6A inhibitors2025
6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors2025
Preparation of maytansinol2025
Synthetic processes and synthetic intermediates2024
Forms and compositions of inhibitors of JAK22024
Cyclopentaimidazolones for the treatment of cancer2024
Pyruvate kinase activators for use in treating blood disorders2024
Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancer2024
6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors2024
6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors2024
Inhibitors of cellular metabolic processes2024